Skip to content

Sun Pharmaceutical Industries Limited Price, Chart & Factor Exposure

Free Data & Analytics Access

Next earnings: Thu, Jan 28, 2027, before the market opens · estimates and history

Sun Pharmaceutical Industries Limited · E.SUNPHARMA.NSE · India
Use symbol E.SUNPHARMA.NSE in our API & Excel add-in to retrieve this data ↓
1,770.00
(0.00%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 0%
Trend -50%
Bubble Risk LOW
Realised Volatility (20D) 13.19%

Sun Pharmaceutical Industries Limited Forecast

Sun Pharmaceutical Industries Limited short-term momentum is neutral (up over 2 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term NEUTRAL signal. The long-term trend is negative (2 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term SELL signal. Based on 20-day realised volatility of 13.2% a year, a typical one-standard-deviation range is 1,737–1,803 over a week, 1,703–1,837 over a month and 1,536–2,004 over a year. (Signals as of 5 Nov 2026.)

Sun Pharmaceutical Industries Limited Price Chart

MacroFinance.ai

Sun Pharmaceutical Industries Limited Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Sun Pharmaceutical Industries Limited
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Sun Pharmaceutical Industries Limited
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Sun Pharmaceutical Industries Limited
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Sun Pharmaceutical Industries Limited
P/E
38.73x
Mid-range vs own history
QoQ +2.6%
YoY −5.2%
now 38.726633.9 low42.05 high
ⓘP/E As of 22 Nov 2026.See Sun Pharmaceutical Industries Limited returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Sun Pharmaceutical Industries Limited
P/S
6.89x
Mid-range vs own history
QoQ −9.6%
YoY −11.3%
now 6.89076.66 low8 high
ⓘP/S As of 22 Nov 2026.See Sun Pharmaceutical Industries Limited returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Sun Pharmaceutical Industries Limited
P/B
4.76x
Mid-range vs own history
QoQ −12.6%
YoY −13.3%
now 4.75684.66 low5.69 high
ⓘP/B As of 22 Nov 2026.See Sun Pharmaceutical Industries Limited returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Sun Pharmaceutical Industries Limited
EV/EBITDA
21.46x
Mid-range vs own history
QoQ −6.1%
YoY −11.7%
now 21.458319.69 low25.04 high
ⓘEV/EBITDA As of 22 Nov 2026.See Sun Pharmaceutical Industries Limited returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Sun Pharmaceutical Industries Limited
EV/Sales
6.40x
Mid-range vs own history
QoQ −10.8%
YoY −13.0%
now 6.39866.18 low7.58 high
ⓘEV/Sales As of 22 Nov 2026.See Sun Pharmaceutical Industries Limited returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Sun Pharmaceutical Industries Limited
Earnings Yield
2.6%
Mid-range vs own history
QoQ −2.6%
YoY +5.5%
now 2.58222.38 low2.95 high
ⓘEarnings Yield As of 22 Nov 2026.See Sun Pharmaceutical Industries Limited returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Sun Pharmaceutical Industries Limited
Market Cap
$4.25T
Mid-range vs own history
QoQ −7.0%
YoY −0.5%
now 4246822.953,827,659 low4,775,876 high
ⓘMarket Cap As of 22 Nov 2026.See Sun Pharmaceutical Industries Limited returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Sun Pharmaceutical Industries Limited
Net Debt
-$303.3B
Low vs own history
QoQ +8.7%
YoY +33.8%
now -303288.3-303,288 low-226,653 high
ⓘNet Debt As of 22 Nov 2026.See Sun Pharmaceutical Industries Limited returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Sun Pharmaceutical Industries Limited
Net Debt / EBITDA
-1.65x
Low vs own history
QoQ +8.5%
YoY +21.2%
now -1.6503-1.65 low-1.36 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Sun Pharmaceutical Industries Limited returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Sun Pharmaceutical Industries Limited
Current Ratio
2.94x
Strong vs own history
QoQ +4.0%
YoY +14.3%
now 2.93612.57 low2.94 high
ⓘCurrent Ratio As of 22 Nov 2026.See Sun Pharmaceutical Industries Limited returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Sun Pharmaceutical Industries Limited
Quick Ratio
2.40x
Strong vs own history
QoQ +3.8%
YoY +13.2%
now 2.40232.12 low2.4 high
ⓘQuick Ratio As of 22 Nov 2026.See Sun Pharmaceutical Industries Limited returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Sun Pharmaceutical Industries Limited
Interest Coverage
45.40x
Mid-range vs own history
QoQ +5.1%
YoY −10.2%
now 45.402543.22 low50.56 high
ⓘInterest Coverage As of 22 Nov 2026.See Sun Pharmaceutical Industries Limited returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Sun Pharmaceutical Industries Limited
Debt / Equity
0.04x
Mid-range vs own history
QoQ −34.4%
YoY −45.8%
now 0.03630.04 low0.07 high
ⓘDebt / Equity As of 22 Nov 2026.See Sun Pharmaceutical Industries Limited returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Sun Pharmaceutical Industries Limited
Piotroski F-Score
4
Mid-range vs own history
QoQ +300.0%
YoY +300.0%
now 41 low4 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Sun Pharmaceutical Industries Limited returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
  15 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  15 members-only factors: Beneish M-Score, Days Sales in Receivables Index, Gross Margin Index, Asset Quality Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Sun Pharmaceutical Industries Limited, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Sun Pharmaceutical Industries Limited fundamentals: income statement, balance sheet & cash flow

Sun Pharmaceutical Industries Limited reported revenue of 584.62bn INR and net income of 114.79bn INR in FY2026, the year ended 31 March 2026 — revenue up 11.2% and net income up 5.0% on the prior year. Free cash flow was 92.42bn INR. These figures are as reported in the filings, not restated: 23 fiscal years and 62 quarters of history, back to March 2004.

Revenue (FY2026)
584.62bn INR
+11.2%
Net income
114.79bn INR
+5.0%
Gross margin
55.70%
Free cash flow
92.42bn INR
-22.6%
Net debt
-69.76bn INR
Sun Pharmaceutical Industries Limited income statement, annual, as reported · INR billions unless stated
INR billionsFY2026FY2025FY2024FY2023FY2022
Period end31 Mar 202631 Mar 202531 Mar 202431 Mar 202331 Mar 2022
Revenue584.62525.78484.97438.86386.54
Cost of revenue259.00115.58114.42113.19108.76
Gross profit325.62410.20370.55325.67277.78
Research & development34.7431.5431.2823.0821.33
Selling, general & admin.—100.5195.0283.5573.54
Operating income135.53278.15244.24219.04182.91
EBITDA183.40151.81130.77118.36103.00
Interest expense3.391.642.381.470.75
Pre-tax income150.63137.37110.4993.6144.65
Income tax35.5427.7214.398.4810.76
Net income114.79109.2995.7684.7432.73

Download Sun Pharmaceutical Industries Limited fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.SUNPHARMA.NSE&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 23 fiscal years and 62 quarters, the filing vintages behind each number and API access.
Create free account

Figures in INR, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.

Research on Sun Pharmaceutical Industries Limited

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Sun Pharmaceutical Industries Limited Trading Strategies

28 backtested tactical asset allocation strategies hold EEM (emerging markets), the closest tradable exposure to Sun Pharmaceutical Industries Limited; 2 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

See all 28 strategies holding EEM →

Statistical Distribution of Returns

Plus

How Sun Pharmaceutical Industries Limited’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Sun Pharmaceutical Industries Limited behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Sun Pharmaceutical Industries Limited (India)

Sun Pharmaceutical Industries Limited is a listed security in India. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is Sun Pharmaceutical Industries Limited?
Sun Pharmaceutical Industries Limited is a listed security in India. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Sun Pharmaceutical Industries Limited price?
The latest close is 1,770 (5 Nov 2026), -0.00% on the day. The price at the top of the page refreshes during the trading day.
Is Sun Pharmaceutical Industries Limited in an uptrend?
As of 5 Nov 2026, short-term momentum is neutral (2 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is negative (2 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Sun Pharmaceutical Industries Limited?
20-day realised volatility is 13.2% a year (5 Nov 2026), which implies a typical one-standard-deviation move of about 3.8% over a month and 1.9% over a week.
What factors affect Sun Pharmaceutical Industries Limited?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Sun Pharmaceutical Industries Limited, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Sun Pharmaceutical Industries Limited?
28 backtested tactical asset allocation strategies trade Sun Pharmaceutical Industries Limited through EEM; 2 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Sun Pharmaceutical Industries Limited returns analysed?
The Statistical Distribution of Returns section shows the distribution of Sun Pharmaceutical Industries Limited daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Sun Pharmaceutical Industries Limited historical data?
In the Free historical data section of this page: the last 10 years of Sun Pharmaceutical Industries Limited daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Sun Pharmaceutical Industries Limited historical data (last 10 years)

Browse or instantly download the last 10 years of Sun Pharmaceutical Industries Limited daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.SUNPHARMA.NSE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-201884.9
2026-11-191900
2026-11-181871.5
2026-11-171870
2026-11-161867.5
2026-11-131880
2026-11-121885
2026-11-111902.3
2026-11-091904.5
2026-11-081915
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, dental, and nutritionals. It also provides generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; specialty medications; antiretrovirals medications; and over-the-counter products, such as vitamins, analgesics, digestives, and lifestyle. In addition, the company offers generics and APIs for anti-cancers, peptides, steroids, sex hormones, immunosuppressant drugs, and controlled substances. Sun Pharmaceutical Industries Limited was founded in 1983 and is headquartered in Mumbai, India.